3 stocks for the biggest drug buying frenzy in history
(details inside)

Demand for weight loss drugs is soaring.

And according to former hedge fund manager Ian King, it’s one of the biggest investment opportunities of 2024.

Called GLP-1 agonists…

But better known by trade names like Ozempic, Wegovy, Mounjaro, and Zepbound…

Sales are up from almost nothing a few years ago…

To $19 billion last year.

And this drug buying frenzy has Wall Street seeing dollar signs.

JP Morgan projects $72 billion in sales by 2030.

Goldman Sachs puts that figure at $100 billion.

Barclays says it could go as high as $200 billion.

That’s up to 10X growth in the coming years.

But you’ll have to act fast if you don’t want to miss out, says Ian King.

He says because of what’s in this official government document, the FDA is about to pour gasoline on this already hot drug buying frenzy…

And ignite one of the biggest money-making opportunities in history.

He’s urging readers to buy three-little known stocks ahead of the official FDA announcement.

Click here for the full story.

Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest — you can lose some or all of your money. Never risk more than you can afford to lose.